Nuwellis (NUWE) EBT Margin Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -222.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -480.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,114.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,391.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -176.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 329.00 |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn | 16,607.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16,607.00 |
| Dec 31, 2025 | 8,251.00 |
| Sep 30, 2025 | 20,842.00 |
| Jun 30, 2025 | -53,389.00 |
| Mar 31, 2025 | 7,389.00 |
| Dec 31, 2024 | 68,457.00 |
| Sep 30, 2024 | 38,402.00 |
| Jun 30, 2024 | -16,349.00 |
| Mar 31, 2024 | 3,904.00 |
| Dec 31, 2023 | -6,314.00 |
| Sep 30, 2023 | 8,395.00 |
| Jun 30, 2023 | -2,298.00 |
| Mar 31, 2023 | -7,492.00 |
| Dec 31, 2022 | 86,692.00 |
| Sep 30, 2022 | 17,275.00 |
| Jun 30, 2022 | 7,046.00 |
| Mar 31, 2022 | 15,675.00 |
| Dec 31, 2021 | 1,789.00 |
| Sep 30, 2021 | 2,667.00 |
| Jun 30, 2021 | 19,174.00 |
| Mar 31, 2021 | 14,776.00 |
| Dec 31, 2020 | 70,502.00 |
| Sep 30, 2020 | 7,339.00 |
| Jun 30, 2020 | 7,396.00 |
| Mar 31, 2020 | -17,579.00 |
| Dec 31, 2019 | 6,594.00 |
| Sep 30, 2019 | 37,327.00 |
| Mar 31, 2018 | 1.15 Mn |
| Dec 31, 2017 | 290,721.00 |
| Sep 30, 2017 | 1.01 Mn |
| Mar 31, 2017 | 1.06 Mn |
| Sep 30, 2016 | 972,599.00 |